athena trial: post adjuvant chemo in ovarian cancer | premal thaker, md, ms | asco22 gyn updates
Published 2 years ago • 214 plays • Length 0:36Download video MP4
Download video MP3
Similar videos
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
3:27
premal thaker, md, ms
-
1:15
doc talk: premal thaker, md, ms on low-grade serous ovarian cancer research | let’s talk about lgsoc
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
18:32
new & novel clinical trials in ovarian cancer
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
57:42
ovarcoming financial toxicity in ovarian cancer
-
9:22
rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...
-
41:55
understanding and navigating treatment options in survivorship & ovarcoming ovarian cancer
-
0:47
phase ii giant trial insights: managing older adults with metastatic pancreatic cancer
-
0:20
ovarian adenocarcinoma
-
52:13
advances - new & in the horizon for ovarian cancer
-
59:44
what clinical trials are recruiting for recurrent ovarian cancer?
-
2:33
new chemotherapy therapies for ovarian cancer
-
1:06:27
parp & clinical trial advances in ovarian cancer
-
22:41
management of ovarian cancer: diagnosis to survivorship and ovarcoming
-
0:50
the ovarian cancer tumor storage center
-
6:42
titan trial
-
1:56
target ovarian cancer - be connected
-
2:09
rucaparib maintenance for recurrent ovarian carcinoma